ARTICLE SUMMARY:
FDA device officials appear to be eyeing the big dollars tied to drug user fee programs with some envy, and other updates from the MDUFA V negotiations.
The device industry’s goal to keep FDA user fees close to current levels in the next round of the program (MDUFA V) is hitting a snag in early negotiation meetings with agency officials who are raising FDA drug user fees as a comparator.
